Sales revenues for September 2012

The Board of Directors of Sopharma AD (the “Company”) notifies that for September 2012 sales revenues remained at the same level compared to the same period of 2011, including 9% decrease of domestic sales and 4% increase of export sales.

During the first nine months of this year Sopharma AD realized an increase of sales revenues of 2%, including 10% decrease of domestic sales and 7% increase of export sales compared to the same period of 2011.